GMTX stock forecast for 2023 – 2027

Are you interested in Gemini Therapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the GMTX stock price in 2022-2027. Is GMTX a good long term stock? When should I take profit in Gemini Therapeutics stock? Buy or sell stock? Will GMTX stock price go up? What are analysts’ forecasts for GMTX stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. GMTX stock returns are also predicted based on historical data.

According to our research, GMTX stock is a bad long-term investment. GMTX share price has been in a bear cycle for the past year. Gemini Therapeutics, Inc. stock trend is negative.

Gemini Therapeutics company info

Industry Biotechnology
Address 300 One Kendall Square, Cambridge, MA, 02139, United States
Website https://www.geminitherapeutics.com

Forecasting

52 Week High: 1.99287 USD
52 Week Low: 0.00000099 USD
1 Year Forecast: 0.00000101 USD
5 Year Forecast: 0 USD

Agilent Technologies info

Market Cap: 77.17M
52 Week Change: -11.21%
52 Week High: 19.085 USD
52 Week Low: 1.66 USD
Beta: 0
50 Day Moving Average: 2.587
90 Day Moving Average: 2.742
200 Day Moving Average: 5.527
Resistance Level: 2.147
Pivot Point: 1.87474
Support Level: 1.69246
Enterprise Value: -17,532,794
Forward P/E: -1.17
Forward EPS: -1.53
Profit Margin: 0.00%
Shares Outstanding: 43,112,700
EBITDA: 0.29
Held Percent Institutions: 71.93%
PEG Ratio (5Y): 0
Trailing EPS: -2.85

Gemini Therapeutics stock forecasts for 2023-2027

DateOpen PriceClose PriceChange

Gemini Therapeutics Stock Forecast for 2023

January 2023 0 0 0%
February 2023 0 0 0%
March 2023 0 0 0%
April 2023 0 0 0%
May 2023 0 0 0%
June 2023 0 0 0%
July 2023 0 0 0%

Other companies stock forecasts